AI-generated summary
This review describes the history and recent progress of using non-damaging laser light as a physical adjuvant to enhance immune responses to vaccines, particularly intradermal vaccines. The authors report that the approach appears to improve responses to both prophylactic and therapeutic vaccines given to laser-exposed skin. The precise molecular mechanism remains unknown, and the authors describe the approach as a potential rather than an established method.
- Limits stated in the abstract
- The abstract states that the precise molecular mechanism of action remains unknown and that the authors' own recent study is a single report, so evidence for the approach is preliminary.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on tandfonline.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Laser, Near-infrared. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.